BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.7 USD | -1.68% |
|
+0.36% | -12.01% |
| 05-16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| 05-16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
Presenter SpeechStelios Papadopoulos (Executives)I will act as Chairman of the meeting as well...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
20/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
227.7
USD
Average target price
285.9
USD
Spread / Average Target
+25.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.01% | 33.72B | |
| -3.23% | 89.69B | |
| +2.50% | 41.34B | |
| +62.74% | 26.11B | |
| -19.79% | 14.63B | |
| -8.58% | 12.84B | |
| -12.34% | 11.66B | |
| -43.92% | 11.52B | |
| +4.27% | 8.92B | |
| -11.58% | 8.38B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc. - Shareholder/Analyst Call
